Search Results - "Milioglou, Ioannis"

Prothrombin complex concentrate in major bleeding associated with DOACs; an updated systematic review and meta-analysis by Milioglou, Ioannis, Farmakis, Ioannis, Neudeker, Mandy, Hussain, Zeeshan, Guha, Avirup, Giannakoulas, George, Kotoula, Vassiliki, Papaioannou, Maria

“…Background Four-factor prothrombin complex concentrate (PCC) is frequently used as a reversal agent for major bleeding in patients on factor Xa inhibitors…”
Get full text

Interpretation of lymphocyte subset counts by the general pediatrician by Milioglou, Ioannis, Kalaitzidou, Ioanna, Ladomenou, Fani

“…The immune system poses one of the greatest challenges for the scientific community. The general pediatrician should be able to screen and identify an…”
Get full text

Idiopathic posterior papillary muscle rupture; a case report by Milioglou, Ioannis, Janko, Matthew R, Hassan, Hafeez Ul, ElHaq, Mohammed, Filby, Steven J, Pelletier, Marc P

“…Papillary muscle rupture is a rare condition. Its clinical presentation, diagnosis and management can be very challenging for the clinician. A 73-year-old…”
Get full text

Patterns of care and outcomes of outpatient percutaneous coronary intervention in the United States: Insights from Nationwide Ambulatory Surgery Sample by Milioglou, Ioannis, Guha, Avirup, Chouari, Fouad, Chaturvedi, Abhishek, Clark, Katherine A.A., Kochar, Ajar, Sung, Jonathan G., Velazquez, Eric J., Ahmad, Tariq, Desai, Nihar R.

Get full text

CHEYNE STOKES BREATHING AND HEART FAILURE: THE PERFECT (VT) STORM? by Milioglou, Ioannis, Budhwar, Anshul, Mackall, Judith, Cakulev, Ivan

Get full text

Thrombocytopenia and Anemia Among Patients with Cerebral Palsy: A Big-Data Analysis by Milioglou, Ioannis, Ahuja, Sanjay P, Stehouwer, Nathan Richard

“…▪ Title: Thrombocytopenia and Anemia among patients with Cerebral Palsy: A big-data analysis Introduction : The incidence of thrombocytopenia and anemia in…”
Get full text

Abstract 12442: A Systematic Review And Network Meta-analysis In HfpEF Pharmacologic Treatment by Zafeiropoulos, Stefanos, Farmakis, Ioannis, Milioglou, Ioannis, Doundoulakis, Ioannis, Stavrakis, Stavros, Giamouzis, Grigorios, Butler, Javed, Giannakoulas, George

“…IntroductionHeart failure with preserved ejection fraction (HFpEF) remains a highly prevalent condition with significant morbidity and mortality but limited…”
Get full text

Abstract 11148: Time-Varying Cardiovascular Effects of Sodium-Glucose Co-Transporter Inhibitors in Patients With Type 2 Diabetes: Insights From Pivotal Cardiovascular Outcome Trials by Milioglou, Ioannis, Motairek, Issam, Deo, Salil, Neeland, Ian, Rajagopalan, sanjay, Al-Kindi, Sadeer

“…IntroductionSodium-glucose co-transporter 2 inhibitors (SGLT2i) have been shown to reduce cardiovascular (CV) risk in patients with type 2 diabetes. Trial…”
Get full text

TCT-229 Percutaneous Thrombectomy in Patients With Pulmonary Embolism and Contraindications for Thrombolysis: A Systematic Review and Meta-Analysis by Milioglou, Ioannis, Farmakis, Ioannis, Wazirali, Mohannad, Ajluni, Steven, Khawaja, Tasveer, Giannakoulas, George, Shishehbor, Mehdi, Li, Jun

Get full text

Bioprosthetic Aortic Valve on the Move by Milioglou, Ioannis, Guillombardo, Carl, Forouzandeh, Farshad

“…[Display omitted] •Acute bioprosthetic aortic valve regurgitation can present with cardiogenic shock.•Echocardiography is critical in the assessment of…”
Get full text

Unusual case of immune-related colitis by Issa, Meltiady, Milioglou, Ioannis

“…The cancer immunotherapy field has had many promising developments in recent years. Checkpoint inhibitors are good examples of that. This new class of…”
Get full text

Percutaneous thrombectomy in patients with intermediate- and high-risk pulmonary embolism and contraindications to thrombolytics: a systematic review and meta-analysis by Milioglou, Ioannis, Farmakis, Ioannis, Wazirali, Mohannad, Ajluni, Steven, Khawaja, Tasveer, Chatuverdi, Abhishek, Giannakoulas, George, Shishehbor, Mehdi, Li, Jun

“…Catheter-directed interventions have slowly been gaining ground in the treatment of pulmonary embolism (PE), especially in patients with increased risk of…”
Get full text

Left Atrial Appendage Closure Outcomes in Patients With Cancer at a Single Tertiary Center by Kumar, Sundeep, Yoon, SungHan, Milioglou, Ioannis, Tashtish, Nour, Farmakis, Ioannis, Dallan, Luis Augusto Palma, Mogalapalli, Akhil, Arruda, Mauricio, Filby, Steven J.

“…Atrial fibrillation is the most common arrhythmia in patients with underlying malignancy. Patients with cancer have a higher risk of bleeding, and at the same…”
Get full text

Abstract 11916: Patterns of Care and Outcomes of Lower Extremity Peripheral Endovascular Intervention in Peripheral Artery Disease: Insights From National Ambulatory Surgery Sample by Chaturvedi, Abhishek, Gertz, Zachary, Lawson, Barbara D, Gupta, Rahul, Milioglou, Ioannis, Sung, Jonathan G, Desai, Nihar R, Vetrovec, George W, Kochar, Ajar, Guha, Avirup

“…IntroductionOver the past 2 decades, the use of peripheral endovascular intervention (PVI) has surpassed surgical revascularization as the primary treatment…”
Get full text

Patterns of Care and Outcomes of Ambulatory Endovascular Interventions in Lower Extremity Peripheral Arterial Disease by Chaturvedi, Abhishek, Castro-Dominguez, Yulanka, Gertz, Zachary M., Lawson, Barbara D., Chandrika, Parul, Gupta, Rahul, Milioglou, Ioannis, Sung, Jonathan G., Desai, Nihar R., Vetrovec, George, Kochar, Ajar, Guha, Avirup

“…Lower extremity endovascular intervention (LE-EVI) is gaining popularity as the primary treatment modality for patients with symptomatic peripheral artery…”
Get full text

Reversal of factor Xa inhibitors associated intracranial haemorrhage at a tertiary medical centre by Milioglou, loannis, Liao, Katherine, Traeger, Jessica, McKenzie, Christy, Burrelli, Correy, Khunayfir, Abdalmalik Khalid Bin, Makii, Jason, Hoffer, Alan

“…Prior to the approval of andexanet, there were no FDA-approved reversal agents indicated for the treatment of factor Xa inhibitor (FXaI) associated major…”
Get full text

INTRAOPERATIVE MORTALITY AND DISPOSITION OF ELECTIVE PCI: INSIGHTS FROM THE NATIONAL AMBULATORY SURGERY SAMPLE by Milioglou, Ioannis, Chouairi, Fouad, Miller, Paul, Ahmad, Tariq, Reinhardt, Samuel, Kay, Bradley, Clark, Katherine, Milner, Aidan, Pacor, Justin, Caraballo, Cesar, Ravindra, Neal, Friedman, Daniel, Desai, Nihar, Guha, Avirup

Get full text

Reversal of factor Xa inhibitors associated intracranial haemorrhage at a tertiary medical centre by Milioglou, Ioannis, Liao, Katherine, Traeger, Jessica, McKenzie, Christy, Burrelli, Correy, Khunayfir, Abdamalik Khalid Bin, Makii, Jason, Hoffer, Alan

“…Prior to the approval of andexanet, there were no FDA-approved reversal agents indicated for the treatment of factor Xa inhibitor (FXaI) associated major…”
Get full text

Time-Varying Cardiovascular Outcomes of Sodium-Glucose Cotransporter Inhibitors in Patients With Type 2 Diabetes: A Post Hoc Analysis of Pivotal Trials Using Restricted Mean Survival Time by Milioglou, Ioannis, Motairek, Issam, Deo, Salil, Ramani, Ravi, Neeland, Ian J., Rajagopalan, Sanjay, Al-Kindi, Sadeer G.

Get full text

Pharmacological Treatments in Heart Failure With Mildly Reduced and Preserved Ejection Fraction by Zafeiropoulos, Stefanos, Farmakis, Ioannis T., Milioglou, Ioannis, Doundoulakis, Ioannis, Gorodeski, Eiran Z., Konstantinides, Stavros V., Cooper, Lauren, Zanos, Stavros, Stavrakis, Stavros, Giamouzis, Grigorios, Butler, Javed, Giannakoulas, George

“…Medical treatment for heart failure with preserved ejection (HFpEF) and heart failure with mildly reduced ejection fraction (HFmrEF) has weaker evidence…”
Get full text